Skip to main content

News Archive

News Archive - All Stories

Interdisciplinary Calit2 Institute to Use Groundbreaking Neural Computing Technology

June 7, 2016

Calit2 is an early partner and will be a user of KnuEdge's new computing architecture inspired by an earlier processor developed in Calit2's Circuits Labs at UC San Diego. The technology could dramatically accelerate machine learning, Big Data analytics and other computations.

Distinguishing Deadly Staph Bacteria from Harmless Strains

June 6, 2016

To better understand the pathogenic bacteria Staphylococcus aureus and develop more effective treatments, University of California San Diego researchers examined the Staph “pan-genome” — the genomes of 64 different strains that differ in where they live, the types of hosts they infect and their antibiotic resistance profiles. This effort, published June 6 by PNAS, places all Staph genes into one of two categories: the core genome or the dispensable genome.

Personalized Medicine Leads to Better Outcomes for Patients with Cancer

June 6, 2016

In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.

Novel Imaging Model Helps Reveal New Therapeutic Target for Pancreatic Cancer

June 6, 2016

Pancreatic ductal adenocarcinoma, the most common of pancreatic cancers, is extraordinarily lethal, with a 5-year survival rate of just 6 percent. In a new study, researchers at University of California San Diego School of Medicine and Moores Cancer Center, together with colleagues at Keio University, the University of Nebraska and Ionis Pharmaceuticals describe an innovative new model that not only allowed them to track drug resistance in vivo, but also revealed a new therapeutic target.

American Gut Project Expands to Asia

June 2, 2016

University of California San Diego School of Medicine researchers are expanding the American Gut Project into Asia. The goal of American Gut, the world’s largest crowdfunded citizen science project, is to sequence as many human microbiomes.

Engineers Launch Cross-Border Center to Create Materials that Withstand Extreme Environments

June 2, 2016

In a few months, a series of laboratories tucked away on the third floor of Jacobs Hall will buzz with teams of researchers and students from UC San Diego and Mexico. Working together, the teams will create materials that can withstand extreme conditions, from the heat of an engine turbine to the cold of space.

Neal Devaraj Named Camille Dreyfus Teacher-Scholar

June 2, 2016

Neal Devaraj, an assistant professor of chemistry and biochemistry at UC San Diego, has been named a Camille Dreyfus Teacher-Scholar by the Camille and Henry Dreyfus Foundation, one of 13 faculty members nationwide to receive the honor.

Building a Defense Against Zika

June 2, 2016

On April 18, 1947, a monkey in Uganda’s Zika Forest fell ill with a fever of 103 degrees Fahrenheit, 4 degrees higher than normal. “Rhesus No. 766” was part of a yellow fever virus study. Scientists took a blood sample. They conducted tests. The rhesus monkey had been stricken by something unknown. In time, the revealed virus would be named after the place where it was first discovered.

Bringing Rigor Back to Science: SciCrunch Supports New NIH Requirements for Biological Citations

June 1, 2016

Ensuring research reproducibility is far from a purely intellectual pursuit: A lack of diligence and consistency can have real-world implications that erode the public’s confidence in scientific research.

Imaging Biomarker Distinguishes Prostate Cancer Tumor Grade

June 1, 2016

Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
Category navigation with Social links